FilingFirehose · free AI preview
FENNEC PHARMACEUTICALS INC.
FENC · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 2
Types: Officer Departure
Fennec Pharmaceuticals (FENC) has filed two officer departure notices in the past 90 days, both triggering 8-K Item 5.02 disclosures—one in late April and another in May 2026. No cyber incidents were detected during this period. The full $49 Report adds detailed context on each departure, dilution risk scoring, a 12-month financing and capital structure review, and AI-driven risk signals across governance and liquidity metrics.
Want the full 5-section $49 Report on FENC?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.